1. Introduction {#sec1-ijms-21-04246}
===============

Bovine spongiform encephalopathy (BSE) is a well-known prion disease characterized by the accumulation of abnormal prion protein (PrP^Sc^), which shows resistance to proteinase K \[[@B1-ijms-21-04246],[@B2-ijms-21-04246],[@B3-ijms-21-04246],[@B4-ijms-21-04246],[@B5-ijms-21-04246],[@B6-ijms-21-04246],[@B7-ijms-21-04246],[@B8-ijms-21-04246],[@B9-ijms-21-04246],[@B10-ijms-21-04246],[@B11-ijms-21-04246],[@B12-ijms-21-04246],[@B13-ijms-21-04246]\]. Classical BSE was first reported in the United Kingdom (UK) in 1986 and has been propagated by PrP^Sc^-contaminated meat and bone meal. Since being controlled by more thorough surveillance of contaminated feed, the number of classical BSE cases has dramatically decreased \[[@B14-ijms-21-04246],[@B15-ijms-21-04246]\]. However, novel forms of BSE and atypical BSEs have been reported in many countries. Unlike classical BSE, the cause of atypical BSE has not been determined \[[@B16-ijms-21-04246],[@B17-ijms-21-04246],[@B18-ijms-21-04246]\].

In humans, prion diseases are classified as sporadic, familial, and infectious forms. Approximately 85% of all human prion diseases are sporadic Creutzfeldt--Jakob disease (CJD). Approximately 15% of all human prion diseases, including familial CJD, Gerstmann--Straussler--Scheinker syndrome (GSS), and fatal familial insomnia (FFI), are known to be caused by a germline mutation of the prion protein gene (*PRNP*) \[[@B19-ijms-21-04246],[@B20-ijms-21-04246]\]. Additionally, \<1% of all human prion diseases, including iatrogenic CJD, variant CJD, and kuru, are acquired by transmission. However, accurate causes of sporadic CJD have not been investigated to date \[[@B21-ijms-21-04246],[@B22-ijms-21-04246]\]. Somatic mutations of the *PRNP* gene have been reported in the blood and brain tissue of sporadic cases of prion diseases. D178N and P102L somatic mutations have been reported in sporadic CJD patients and sporadic GSS symptom patients, respectively \[[@B23-ijms-21-04246],[@B24-ijms-21-04246]\]. The commonality of these patients is that they were caused by somatic mutations, and not germline mutations inherited from their parents. Thus, somatic mutation of the *PRNP* gene was assumed to be one cause of sporadic prion diseases, in which no cause has been identified to date. In cattle, the E211K mutation of the bovine *PRNP* gene, which is homologous to the E200K mutation of the human *PRNP* gene found in familial CJD, was first reported in atypical BSE in the United States in 2006 \[[@B25-ijms-21-04246],[@B26-ijms-21-04246],[@B27-ijms-21-04246]\]. At present, since atypical BSEs, which may refer to sporadically occurring BSE, have been occurring steadily in many countries, it is important to investigate the somatic mutation on E211K of the *PRNP* gene in cattle.

In this study, we investigated the E211K somatic mutation of the *PRNP* gene in Korean cattle using pyrosequencing. We collected peripheral whole blood and several types of tissue in cattle, including the medulla oblongata, cerebellum, cortex, thalamus, and skin tissue. We purified the genomic DNA from each tissue and blood and performed pyrosequencing to identify the E211K somatic mutation of the bovine *PRNP* gene. Furthermore, we estimated a deleterious effect of the E211K somatic mutation on bovine prion protein by in silico evaluation tools such as PolyPhen-2 and PANTHER \[[@B28-ijms-21-04246],[@B29-ijms-21-04246]\].

2. Results {#sec2-ijms-21-04246}
==========

2.1. Sample Preparation {#sec2dot1-ijms-21-04246}
-----------------------

We collected samples from peripheral blood and five tissues, including the medulla oblongata, cerebellum, cortex, thalamus, and skin. Detailed information on the collected samples is described in [Table 1](#ijms-21-04246-t001){ref-type="table"}. DNA extraction was performed with peripheral blood and brain tissues, and all DNA samples were subjected to quality checks using the A260/A280 ratio with 1.8--2.0 values.

2.2. Validation of the Inspection Tool {#sec2dot2-ijms-21-04246}
--------------------------------------

To investigate the somatic mutation of K211 in the bovine *PRNP* gene, we performed pyrosequencing analysis, which is known as a convenient tool to measure somatic mutations with low frequencies. Detailed information is described in [Figure 1](#ijms-21-04246-f001){ref-type="fig"}a. The polymerase chain reaction (PCR) products containing the mutation site at codon 211 of the bovine *PRNP* gene were amplified using biotinylated forward and non-biotinylated reverse primers ([Table 2](#ijms-21-04246-t002){ref-type="table"}). The pyrosequencing primer set (forward, reverse, and sequencing primer) was generated using PyroMark Assay Design (QIAGEN, Germany). To verify the accuracy of the detection of pyrosequencing, we synthesized the K211 mutant gene using PCR-based site-directed mutagenesis. Biotinylated PCR products were confirmed on a gel with a length of 155 bp ([Figure 1](#ijms-21-04246-f001){ref-type="fig"}b). Before the pyrosequencing analysis, we confirmed the K211 mutation of the standard material by Sanger sequencing ([Figure 1](#ijms-21-04246-f001){ref-type="fig"}c). Then, we mixed standard material of the E211 normal gene with that of K211 mutant genes at specific ratios. According to the manufacturer's recommendation, reliable detection and quantification of sequence variation using pyrosequencing is above 5% mutation. Thus, we excluded the dilutions of extremely low levels (0.1--3%). Each experiment was performed in duplicate. The mutation rate, which was observed using pyrosequencing, showed a high correlation with the expected mutation rate (*R*^2^ = 0.9984, [Figure 2](#ijms-21-04246-f002){ref-type="fig"}).

2.3. Investigation of K211 Somatic Mutation of Bovine PRNP Gene in Korean Cattle {#sec2dot3-ijms-21-04246}
--------------------------------------------------------------------------------

We performed pyrosequencing to examine the K211 somatic mutation of the *PRNP* gene in 58 brain and blood samples of Hanwoo and Holstein cattle. Detailed information on the pyrosequencing results is shown in [Table 3](#ijms-21-04246-t003){ref-type="table"}. Among the 58 samples, three samples of the medulla oblongata of Holstein cattle, including samples 11, 16, and 18, showed somatic mutation rates of \>10% ([Table 3](#ijms-21-04246-t003){ref-type="table"}). The comparison of detection results between 0% negative standard and four bovine samples was analyzed using the Student's *t*-test. Notably, samples 11 (10% ± 4.4%), 16 (28% ± 2%), and 18 (19.55% ± 3.1%) showed significantly high K211 somatic mutation rates ([Table 3](#ijms-21-04246-t003){ref-type="table"} and [Figure 3](#ijms-21-04246-f003){ref-type="fig"}).

2.4. In Silico Estimation of the Deleterious Effect of K211 Somatic Mutation of Bovine Prion Protein {#sec2dot4-ijms-21-04246}
----------------------------------------------------------------------------------------------------

To validate the prediction effectiveness of the annotation software, prior to the analysis of the K211 somatic mutation of the bovine *PRNP* gene, we analyzed the previously reported pathogenic *PRNP* mutations related to human genetic prion diseases. Although six mutations of human *PRNP* (D167N, V180I, V203I, I215V, M232R, and M232T) were predicted to be deleterious by only one program, the remaining 34 pathogenic mutations were predicted to be deleterious by PolyPhen-2 and PANTHER ([Supplementary Table S1](#app1-ijms-21-04246){ref-type="app"}). We estimated the biological impact of the somatic mutation c.631G\>A (E211K) of the bovine *PRNP* gene using in silico programs, including PolyPhen-2 and PANTHER. PolyPhen-2 and PANTHER predicted that E211K was "probably damaging" with a score of 0.993 and "possibly damaging" with a score of 361, respectively ([Table 4](#ijms-21-04246-t004){ref-type="table"}).

3. Discussion {#sec3-ijms-21-04246}
=============

Although the number of classical BSE cases caused by contaminated meat and bone meal has decreased dramatically due to global efforts, the number of atypical BSE cases increased \[[@B30-ijms-21-04246],[@B31-ijms-21-04246]\]. In humans, genetic prion disease makes up approximately 10% to 15% of cases with germline mutations of the *PRNP* gene \[[@B19-ijms-21-04246]\]. However, although sporadic prion disease accounts for 85% of human prion diseases, the exact cause of sporadic prion disease has not been revealed to date. In recent studies, somatic mutations in the *PRNP* gene have been identified in human sporadic prion diseases and have been suggested as one cause of sporadic prion disease. In cattle, the E211K germline mutation of the bovine *PRNP* gene was first reported in the United States in 2006 \[[@B25-ijms-21-04246],[@B26-ijms-21-04246],[@B27-ijms-21-04246]\]. The bovine E211K mutation showed homology in the region with the E200K mutation of the human *PRNP* gene, which is most frequently observed in human familial prion diseases \[[@B20-ijms-21-04246],[@B22-ijms-21-04246]\]. Thus, we investigated the E211K somatic mutation of the bovine *PRNP* gene, which may be considered a novel risk factor for BSE in Korean cattle.

In our previous study, the germline mutation at codon 211 of the bovine *PRNP* gene was not observed in 384 Hanwoo cattle and 152 Holstein cattle \[[@B5-ijms-21-04246]\]. Remarkably, we found high rates of K211 somatic mutation of the bovine *PRNP* gene in three Holstein cattle ([Table 3](#ijms-21-04246-t003){ref-type="table"}). In Korea, since classical and atypical BSEs have never been reported in Hanwoo, the absence of K211 somatic mutations in Hanwoo is notable. In addition, although we tested K211 somatic mutations, including whole blood and four brain regions, somatic mutations of this gene were detected only in the medulla oblongata. The expected level of K211 mutations of the bovine *PRNP* gene, which can initiate atypical BSE, is elusive. A previous study in early-onset Alzheimer's disease reported that 14% of mutations of the presenilin 1 (*PSEN1*) gene in brain cells are responsible for the initiation of this disease \[[@B32-ijms-21-04246]\]. In another study, the somatic mutations of amyloid precursor protein (*APP*), nicastrin (*NCSTN*), sortilin-related receptor (*SORL1*), and microtubule affinity-regulating kinase 4 (*MARK4*) were observed in sporadic Alzheimer's disease patients in 0.2--10.5% \[[@B33-ijms-21-04246]\]. We observed three samples containing over 10% K211 mutations ([Figure 3](#ijms-21-04246-f003){ref-type="fig"}). Thus, BSE inspection of these samples seems essential to elucidate the expected level of K211 mutations of the *PRNP* gene, which can initiate atypical BSE in the future.

According to previous studies, since the medulla oblongata showed a prominent accumulation of PrP^Sc^, the diagnosis of BSE was performed in the medulla oblongata region \[[@B34-ijms-21-04246]\]. However, since the three Holstein cattle carrying the K211 somatic mutation in the medulla oblongata were not investigated as to whether K211 somatic mutation could be observed in other brain regions, it is difficult to conclude that this somatic mutation was only found in the medulla oblongata. In addition, since atypical BSE has shown to be a prominent brain pathology in the frontal cortex \[[@B17-ijms-21-04246],[@B18-ijms-21-04246]\], if the atypical BSE was caused by a somatic mutation of the *PRNP* gene, it is expected that the somatic mutation was also found in the cerebral cortex. Thus, further investigation of the K211 somatic mutation is highly desirable in other brain regions, including the cerebral cortex of the three Holstein cattle carrying K211 somatic mutation in the medulla oblongata. We also performed in silico analysis using PolyPhen-2 and PANTHER to evaluate whether the mutation of K211 of the bovine *PRNP* gene affects the bovine PrP protein. Notably, the K211 somatic mutation of the bovine *PRNP* gene was evaluated as "damaging". Since PolyPhen-2 can estimate structural variation, the prediction can be interpreted that K211 somatic mutation can contribute to the conformational change to the susceptible structure of the PrP^Sc^. In addition, the wild-type PrP with E211 allele was predicted to be of high preservation time (361, [Table 4](#ijms-21-04246-t004){ref-type="table"}) and K211 somatic mutation was estimated to be deleterious by using the PANTHER program. The prediction of PANTHER indicated that K211 mutation has been very rare and has not been observed in ancestral proteins for a long time. To confirm the effect of K211 mutation on prion disease, investigation of symptoms of prion disease in bovine PrP transgenic mice carrying the K211 allele is highly desirable in the future. It seems possible that a high somatic mutation rate contributes to sporadic prion disease in cattle.

Previous studies have reported that prion disease is accelerated in transgenic (Tg) mice expressing wild-type bank vole prion protein (BVPrP) containing E200K, which is associated with human familial CJD \[[@B35-ijms-21-04246]\]. In addition, recent studies have demonstrated that a human PrP Tg mouse model with the E200K mutation can lead to spontaneous prion disease \[[@B36-ijms-21-04246]\]. In cattle, the E211K mutation, which is a homologous region of human E200K, is expected to have a deleterious effect on BSE, and several in silico programs in the present study are expected to cause structural changes in the bovine prion protein ([Table 4](#ijms-21-04246-t004){ref-type="table"}). To determine whether the E211K mutation affects the susceptibility to prion disease, brain samples with high mutation rates of E211K should be investigated by protein misfolding cyclic amplification (PMCA) or Western blotting (WB) in the future.

4. Materials and Methods {#sec4-ijms-21-04246}
========================

4.1. Ethics Statement {#sec4dot1-ijms-21-04246}
---------------------

Peripheral whole blood, brain, and skin tissues were collected from slaughterhouses in the Republic of Korea. All experimental procedures were approved by the Institute of Animal Care and Use Committee of Jeonbuk National University (JBNU 2018-079) and approved on 1 October 2018. All experiments using cattle were performed following the Korean Experimental Animal Protection Act.

4.2. Genomic DNA Extraction {#sec4dot2-ijms-21-04246}
---------------------------

Genomic DNA was extracted from 20 mg of tissue using a Tissue Genomic DNA Isolation kit (QIAGEN, Germantown, MD, USA) and 200 µL of blood using a Blood Genomic DNA Isolation kit (QIAGEN, USA) following the manufacturer's instructions.

4.3. PCR {#sec4dot3-ijms-21-04246}
--------

PCR was performed using *Taq* DNA Polymerase (QIAGEN, Hilden, Germany) following the manufacturer's instructions. The PCR mixture contained 20 pmol of each primer, 5 µL of 10× *Taq* DNA polymerase buffer, 1 μL of 10 mM dNTP mixture, and 2.5 units of *Taq* DNA polymerase. The PCR conditions for each primer are described in [Table 1](#ijms-21-04246-t001){ref-type="table"}. PCR was performed using an S-1000 Thermal Cycler (Bio-Rad, Hercules, CA, USA).

4.4. Site-Directed Mutagenesis {#sec4dot4-ijms-21-04246}
------------------------------

PCR-based site-directed mutagenesis was performed to obtain a DNA fragment of mutant type K211 of the bovine *PRNP* gene, which was used as a positive control. Briefly, 4 oligonucleotide primers were synthesized to carry out site-directed mutagenesis. Detailed information on the primers and experimental conditions is described in [Table 1](#ijms-21-04246-t001){ref-type="table"}. In the first round of PCR, each pair (F1 pair and F2 pair) was amplified from a targeted region of the bovine *PRNP* gene. The second round of PCR was performed by F1_F and F2_R primer pairs, and amplicons amplified by the F1 pair and F2 pair were used as templates to obtain a DNA fragment of mutant K211 of the bovine *PRNP* gene.

4.5. Sanger Sequencing {#sec4dot5-ijms-21-04246}
----------------------

The PCR products were purified using a PCR Purification Kit (Thermo Fisher Scientific, Bridgewater, NJ, USA) and directly analyzed with an ABI 3730 automatic sequencer (ABI, Foster City, CA, USA). Sequencing results were read by Finch TV software (Geospiza Inc., Seattle, WA, USA).

4.6. Pyrosequencing {#sec4dot6-ijms-21-04246}
-------------------

Pyrosequencing was performed using biotinylated amplicons of the bovine *PRNP* gene by PCR. Briefly, the genomic DNA (10 ng) isolated from cattle was amplified by PCR using a biotinylated forward primer and a non-biotinylated reverse primer. Detailed information on the primers and PCR conditions is described in [Table 1](#ijms-21-04246-t001){ref-type="table"}. The PCR products (25 µL) were mixed with 2 µL Streptavidin Sepharose High-Performance medium (GE Healthcare, Madison, WI, USA), 40 µL PyroMark Binding Buffer (QIAGEN, USA), and 8.5 µL high-purity autoclaved water, and centrifuged for 15 min at 14,000 rpm. The resulting products were washed with 70% ethanol for 10 s, PyroMark denaturation buffer (QIAGEN, USA) for 10 s, and PyroMark wash buffer (QIAGEN, USA) for 10 s, and then mixed with 24.2 µL PyroMark annealing buffer (QIAGEN, USA) and 0.8 µL sequencing primer (2 µM). Finally, the prepared samples were loaded into the PyroMark Q24 (QIAGEN, USA) and operated in the allele quantification (AQ) mode according to the manufacturer's protocol.

4.7. Statistical Analysis {#sec4dot7-ijms-21-04246}
-------------------------

Three independent experiments were carried out, and the data were reported as the mean values ± standard deviation (SD). Statistical significance using the *p*-value was calculated with SAS version 9.4 (SAS Institute Inc., Cary, NC, USA) using a two-tailed Student's *t*-test for single comparisons. The symbols \*\*, and \*\*\* indicate *p* \< 0.01, and *p* \< 0.001, respectively.

4.8. In Silico Estimation of the Impact of E211K Somatic Mutation of the Bovine Prion Protein {#sec4dot8-ijms-21-04246}
---------------------------------------------------------------------------------------------

A deleterious effect of somatic mutation E211K in bovine prion protein was evaluated by the PolyPhen-2 (<http://genetics.bwh.harvard.edu/pph2/index.shtml>) and PANTHER (<http://www.pantherdb.org/>) programs. PolyPhen-2 analyzed the impact of amino acid substitution on the protein of interest based on various features, including the functional or binding properties of sequence, phylogenetic property, and 3D structural information characterizing the substitution. PANTHER predicted the likelihood of a specific amino acid substitution in causing a functional impact on the protein by calculating the length of time that a given amino acid has been evolutionarily preserved to the protein of interest. The length of the preservation time is proportional to the magnitude of the likelihood of the functional impact.

5. Conclusions {#sec5-ijms-21-04246}
==============

In this study, we first identified a total of three high somatic mutation rates of E211K in three Holsteins using pyrosequencing. Next, we performed in silico estimation of the E211K mutation of the bovine *PRNP* gene using PolyPhen-2 and PANTHER, and it was predicted to be damaging. To the best of our knowledge, this study was the first to investigate potential BSE-associated K211 somatic mutations of the bovine *PRNP* gene.
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![(**a**) Schematic design of pyrosequencing to detect the E211K somatic mutation of the bovine prion protein gene (*PRNP*). (**b**) Gene-specific primers were used to obtain 155 bp amplicons of the bovine *PRNP* gene containing K211 mutation and E211 wild type. Marker: 100 bp DNA ladder marker; Mut: K211 mutation sample; CTL: E211 normal sample. (**c**) Electropherograms of Sanger sequencing results. The upper panel indicates Sanger sequencing results of the DNA amplicon with 100% E211 normal sample. The middle panel indicates Sanger sequencing results of mixed DNA amplicons with 50% E211 normal sample and 50% K211 mutation sample. The lower panel indicates Sanger sequencing results of DNA amplicon with 100% K211 mutation sample.](ijms-21-04246-g001){#ijms-21-04246-f001}

![Validation of the detection accuracies of pyrosequencing. The scatter plot indicates the average of the observed somatic mutation rates of the standard materials with mutation rates of 100%, 50%, 25%, 12.5%, 6%, 3%, and 0%. Regression analysis was performed to determine the correlation between the observed somatic mutation rates and the expected somatic mutation rates.](ijms-21-04246-g002){#ijms-21-04246-f002}

![Representative results on the K211 somatic mutation rates of the bovine prion protein gene (*PRNP*) using pyrosequencing. Negative: standard material with 0% somatic mutation rates; Sample 1: Hanwoo, medulla oblongata; Sample 11: Holstein, medulla oblongata; Sample 16: Holstein, medulla oblongata; Sample 18: Holstein, medulla oblongata. All experiments were repeated three times. \*\* indicates *p* \< 0.01 and \*\*\* indicates *p* \< 0.001.](ijms-21-04246-g003){#ijms-21-04246-f003}

ijms-21-04246-t001_Table 1

###### 

Detailed information of the bovine samples used.

  Inspection Site    Sex                 Hanwoo   Holstein   
  ------------------ ------------------- -------- ---------- ---
  Brain              Medulla oblongata   Male     5          5
  Female             5                   5                   
  Cerebellum         Male                         3          
  Female             3                                       
  Cortex             Male                         3          
  Female             3                                       
  Thalamus           Male                         3          
  Female             3                                       
  Peripheral blood                       NA       5          5
  Skin tissue                            NA       5          5

NA: not available.

ijms-21-04246-t002_Table 2

###### 

Detailed information on the primer set used.

  Purpose                     Name                                 Sequence                             Size                      Annealing Temperature   
  --------------------------- ------------------------------------ ------------------------------------ ------------------------- ----------------------- -------
  Site-directed mutagenesis   Round 1                              F1_F                                 ATGGTGAAAAGCCACATAGGCAG   652 bp                  55 °C
  F1_R                        CCATCATCTTGATGTCAGTTTtGGTGAAGTTCTC                                                                                          
  Round 1                     F2_F                                 GAGAACTTCACCaAAACTGACATCAAGATGATGG   204 bp                    55 °C                   
  F2_R                        GATAATGAAAACAGGAAGGTTGCCCC                                                                                                  
  Round 2                     F1_F                                 ATGGTGAAAAGCCACATAGGCAG              820 bp                    55 °C                   
  F2_R                        GATAATGAAAACAGGAAGGTTGCCCC                                                                                                  
  Pyrosequencing              Amplification                        Biotin_PF                            ACTTTGTGCATGACTGTGTCAA    155 bp                  58 °C
  PR                          ATAAGCCTGGGATTCTCTCTGG                                                                                                      
  Sequencing                  Seq_R                                CCATCATCTTGATGTCAGT                                                                    

ijms-21-04246-t003_Table 3

###### 

K211 somatic mutation rates of the prion protein gene (*PRNP*) observed in Hanwoo and Holstein cattle.

  Sample No.   Breeds     Sex      Inspection Site     \* AVG of Detected Mut. (%)   \*\* STD
  ------------ ---------- -------- ------------------- ----------------------------- ----------
  Sample 1     Hanwoo     Female   Medulla oblongata   0                             0
  Sample 2     Hanwoo     Female   Medulla oblongata   0                             0
  Sample 3     Hanwoo     Female   Medulla oblongata   0                             0
  Sample 4     Hanwoo     Female   Medulla oblongata   0                             0
  Sample 5     Hanwoo     Female   Medulla oblongata   0                             0
  Sample 6     Hanwoo     Male     Medulla oblongata   0                             0
  Sample 7     Hanwoo     Male     Medulla oblongata   0                             0
  Sample 8     Hanwoo     Male     Medulla oblongata   0                             0
  Sample 9     Hanwoo     Male     Medulla oblongata   0                             0
  Sample 10    Hanwoo     Male     Medulla oblongata   0                             0
  Sample 11    Holstein   Female   Medulla oblongata   10                            4.4
  Sample 12    Holstein   Female   Medulla oblongata   0                             0
  Sample 13    Holstein   Female   Medulla oblongata   0                             0
  Sample 14    Holstein   Female   Medulla oblongata   0                             0
  Sample 15    Holstein   Female   Medulla oblongata   0                             0
  Sample 16    Holstein   Male     Medulla oblongata   28                            2
  Sample 17    Holstein   Male     Medulla oblongata   0                             0
  Sample 18    Holstein   Male     Medulla oblongata   19.55                         3.1
  Sample 19    Holstein   Male     Medulla oblongata   0                             0
  Sample 20    Holstein   Male     Medulla oblongata   0                             0
  Sample 21    Hanwoo     Female   Cerebellum          0                             0
  Sample 22    Hanwoo     Female   Cerebellum          0                             0
  Sample 23    Hanwoo     Female   Cerebellum          0                             0
  Sample 24    Holstein   Male     Cerebellum          0                             0
  Sample 25    Holstein   Male     Cerebellum          0                             0
  Sample 26    Holstein   Male     Cerebellum          0                             0
  Sample 27    Hanwoo     Female   Cortex              0                             0
  Sample 28    Hanwoo     Female   Cortex              0                             0
  Sample 29    Hanwoo     Female   Cortex              0                             0
  Sample 30    Holstein   Male     Cortex              0                             0
  Sample 31    Holstein   Male     Cortex              0                             0
  Sample 32    Holstein   Male     Cortex              0                             0
  Sample 33    Hanwoo     Female   Thalamus            0                             0
  Sample 34    Hanwoo     Female   Thalamus            0                             0
  Sample 35    Hanwoo     Female   Thalamus            0                             0
  Sample 36    Holstein   Male     Thalamus            0                             0
  Sample 37    Holstein   Male     Thalamus            0                             0
  Sample 38    Holstein   Male     Thalamus            0                             0
  Sample 39    Hanwoo     NA       Peripheral blood    0                             0
  Sample 40    Hanwoo     NA       Peripheral blood    0                             0
  Sample 41    Hanwoo     NA       Peripheral blood    0                             0
  Sample 42    Hanwoo     NA       Peripheral blood    0                             0
  Sample 43    Hanwoo     NA       Peripheral blood    0                             0
  Sample 44    Holstein   NA       Peripheral blood    0                             0
  Sample 45    Holstein   NA       Peripheral blood    0                             0
  Sample 46    Holstein   NA       Peripheral blood    0                             0
  Sample 47    Holstein   NA       Peripheral blood    0                             0
  Sample 48    Holstein   NA       Peripheral blood    0                             0
  Sample 49    Hanwoo     NA       Skin tissue         0                             0
  Sample 50    Hanwoo     NA       Skin tissue         0                             0
  Sample 51    Hanwoo     NA       Skin tissue         0                             0
  Sample 52    Hanwoo     NA       Skin tissue         0                             0
  Sample 53    Hanwoo     NA       Skin tissue         0                             0
  Sample 54    Holstein   NA       Skin tissue         0                             0
  Sample 55    Holstein   NA       Skin tissue         0                             0
  Sample 56    Holstein   NA       Skin tissue         0                             0
  Sample 57    Holstein   NA       Skin tissue         0                             0
  Sample 58    Holstein   NA       Skin tissue         0                             0

\* AVG of detected mut. (%): average of detected percentage of K211 mutations; \*\* STD: standard deviation; NA: not available.

ijms-21-04246-t004_Table 4

###### 

In silico evaluation of the impact of K211 somatic mutation on the bovine prion protein.

  -----------------------------------------------------------------------
  Somatic Mutation   Methods      Score               Prediction
  ------------------ ------------ ------------------- -------------------
  c.631G \> A\       PolyPhen-2   0.993               Probably damaging
  (E211K)                                             

  PANTHER            361          Possibly damaging   
  -----------------------------------------------------------------------

[^1]: These authors contributed equally to this work.
